Ketamine & Wellness Clinic of South Florida
41 North Federal Highway, Suite A, Pompano Beach
4.9(92 Google reviews)
United States
1 listed treatment center serving Pompano Beach and the surrounding area.
41 North Federal Highway, Suite A, Pompano Beach
4.9(92 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Pompano Beach.
8 miles away · Fort Lauderdale
1212 East Broward Boulevard, Suite 204, Fort Lauderdale
4.6(52 Google reviews)
8 miles away · Coral Springs
1725 North University Drive, 350, Coral Springs
4.2(433 Google reviews)
8.8 miles away · Lauderhill
4300 North University Drive, Suite Suite F100, Lauderhill
4.2(5 Google reviews)
9.2 miles away · Plantation
4100 South Hospital Drive, Suite 102, Plantation
4.9(87 Google reviews)
10.8 miles away · Plantation
7540 Northwest 5th Street, Suite 2, Plantation
4.9(32 Google reviews)
The cost of SPRAVATO® treatment in Pompano Beach depends on your insurance benefits, treatment setting, and prescribed schedule. Both the medication and the supervised treatment and monitoring visit may be billed. Ask for an estimate that includes all components, rather than assuming a medication quote represents the entire visit.
Prior authorization is common. Your insurer may request documentation of earlier antidepressant trials, including which medicines you tried and how you responded. Ask the treatment center which records it needs, who submits the authorization request, and how you will learn whether approval has been granted. Authorization does not necessarily mean you will have no out-of-pocket costs.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. Florida Medicaid coverage also depends on the plan and setting. The Pompano Beach listing currently indicates that it does not accept Medicare or Medicaid; confirm this directly, since a directory listing is not a benefits determination. An empty insurance list does not establish which commercial plans a center accepts.
Manufacturer savings programs exist for eligible commercially insured patients, not patients using government insurance. Ask about current eligibility rules and which charges a program may help with; do not assume it covers the monitoring visit.
Before starting, ask the center and insurer:
SPRAVATO® treatment takes place only in a REMS-certified healthcare setting. You self-administer the nasal spray under a healthcare provider’s direct observation; it is never sent home with you. This directory lists one Pompano Beach center as offering Spravato, but its REMS certification has not been verified in the listing. Confirm certification directly before scheduling.
Plan for at least two hours of monitoring after each dose, plus time for check-in, preparation, and discharge assessment. The appointment may therefore take longer than two hours. The typical labeled schedule starts twice weekly for weeks 1–4, then weekly for weeks 5–8, followed by weekly or every-two-week maintenance visits. Your prescriber individualizes the schedule, so ask which visit pattern applies to your treatment rather than assuming a fixed calendar.
You must arrange for someone else to drive you home. Do not drive or operate machinery until the next day after a restful sleep. Before booking, ask the center about its pickup and accompanying-person requirements. Coordinate rides with a trusted person or ask whether another transportation arrangement meets the center’s safety policy. A backup ride plan can help prevent last-minute cancellations.
Discuss time off work around the full appointment and transportation, particularly during the early, more frequent visits. If your work involves driving or machinery, account for the next-day restriction too.
If no Pompano Beach center is listed when you search, or the listed option cannot meet your needs, you can check listings in Hollywood, West Palm Beach, or Miami. These cities have listed centers, but certification, appointment availability, insurance participation, and transportation arrangements still need direct confirmation.
The directory currently lists one Pompano Beach center offering SPRAVATO®, but its REMS certification status is not verified in the listing. Ask the center directly whether it is currently REMS-certified to provide treatment. If it cannot meet your needs, check listings in Hollywood, West Palm Beach, or Miami, then confirm certification, appointment availability, and insurance participation before making plans.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved, together with an oral antidepressant, for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior. It is not approved for children. A clinician must review your symptoms, treatment history, and medical risks to determine whether it is appropriate; a directory listing cannot establish eligibility.
Coverage depends on your plan and treatment setting. Prior authorization and records of previous antidepressant trials are commonly requested. Ask about coverage for both the medication and the observed monitoring visit. The local listing indicates it does not accept Medicare or Medicaid, but confirm directly. Medicare and Florida Medicaid may cover treatment in some circumstances; that does not mean every center accepts them.
You use the nasal spray yourself under direct observation at a REMS-certified healthcare setting. After each dose, the team monitors you for at least two hours, including for sedation, dissociation, breathing problems, and blood pressure increases. Allow additional time for preparation and discharge assessment. You cannot take Spravato home, and you need someone else to drive you home after the appointment.
Spravato can cause sedation, dissociation—a feeling of being disconnected from yourself or your surroundings—breathing problems, and blood pressure increases. Its boxed warnings also address abuse and misuse and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss these risks with your prescriber and tell staff promptly if you feel unwell during treatment. Monitoring is required even if an earlier visit went smoothly.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Its approval for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior requires use with an oral antidepressant. If you are in crisis, call or text 988. For immediate danger or a medical emergency, call 911 rather than waiting for a treatment appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.